INTRODUCTION: The cortisol-induced increase in von Willebrand factor (VWF) in Cushing's syndrome (CS) seems to depend on single nucleotide polymorphisms (SNPs) of the VWF promoter, haplotype 1 (-3268G/-2709C/-2661A/-2527G) being the susceptible pattern. MATERIALS AND METHODS: This study focused on a new variable region of the VWF promoter, the -2144(GT)(n) locus, to establish whether different GT-repeat lengths are also involved in modulating the cortisol-induced increase in VWF. Sixty-nine CS patients were investigated, divided into groups A (high VWF) and B (normal VWF). RESULTS: Analysing the (GT)(n) locus revealed a similar allele distribution in CS patients and normal subjects, (GT)(n) variants ranging from 15 to 24 repeats and (GT)(19) and (GT)(21) being the two most represented. However, when groups A and B were analysed separately, a different allele distribution was observed: short GT-repeats (15-19, GT(S)) were more frequent in group A, long GT-repeats (20-24, GT(L)) in group B (p=0.01). About genotype distributions, (GT)(S)/(GT)(S) was higher in group A and rare in group B (22.5% and 3.4%, respectively), whereas (GT)(L)/(GT)(L) was higher in group B than in group A (55.2%, 27.5%) (p=0.021). Odds-ratio analysis revealed a risk of a cortisol-dependent increase in VWF three times higher for alleles (GT)(S) than for (GT)(L), and 13-fold for genotype (GT)(S)/(GT)(S) respect to (GT)(L)/(GT)(L). CONCLUSIONS: In conclusion, not only the SNPs haplotypes in the VWF gene promoter, but also the variable-length (GT)(n) locus predict the risk of developing high VWF levels under conditions of glucocorticoid excess; the combination of (GT)(S) and haplotype 1 represents the susceptible pattern. Copyright 2010 Elsevier Ltd. All rights reserved.
INTRODUCTION: The cortisol-induced increase in von Willebrand factor (VWF) in Cushing's syndrome (CS) seems to depend on single nucleotide polymorphisms (SNPs) of the VWF promoter, haplotype 1 (-3268G/-2709C/-2661A/-2527G) being the susceptible pattern. MATERIALS AND METHODS: This study focused on a new variable region of the VWF promoter, the -2144(GT)(n) locus, to establish whether different GT-repeat lengths are also involved in modulating the cortisol-induced increase in VWF. Sixty-nine CS patients were investigated, divided into groups A (high VWF) and B (normal VWF). RESULTS: Analysing the (GT)(n) locus revealed a similar allele distribution in CS patients and normal subjects, (GT)(n) variants ranging from 15 to 24 repeats and (GT)(19) and (GT)(21) being the two most represented. However, when groups A and B were analysed separately, a different allele distribution was observed: short GT-repeats (15-19, GT(S)) were more frequent in group A, long GT-repeats (20-24, GT(L)) in group B (p=0.01). About genotype distributions, (GT)(S)/(GT)(S) was higher in group A and rare in group B (22.5% and 3.4%, respectively), whereas (GT)(L)/(GT)(L) was higher in group B than in group A (55.2%, 27.5%) (p=0.021). Odds-ratio analysis revealed a risk of a cortisol-dependent increase in VWF three times higher for alleles (GT)(S) than for (GT)(L), and 13-fold for genotype (GT)(S)/(GT)(S) respect to (GT)(L)/(GT)(L). CONCLUSIONS: In conclusion, not only the SNPs haplotypes in the VWF gene promoter, but also the variable-length (GT)(n) locus predict the risk of developing high VWF levels under conditions of glucocorticoid excess; the combination of (GT)(S) and haplotype 1 represents the susceptible pattern. Copyright 2010 Elsevier Ltd. All rights reserved.
Authors: N Hickson; D Hampshire; G Castaman; J Eikenboom; F Rodeghiero; I Peake; A Goodeve Journal: J Thromb Haemost Date: 2011-03 Impact factor: 5.824
Authors: Marco Antonio Meraz-Ríos; Abraham Majluf-Cruz; Carla Santana; Gino Noris; Rafael Camacho-Mejorado; Leonor C Acosta-Saavedra; Emma S Calderón-Aranda; Jesús Hernández-Juárez; Jonathan J Magaña; Rocío Gómez Journal: Biomed Res Int Date: 2014-08-31 Impact factor: 3.411